Inhibition of the potassium channel TASK-1 in human atria to reduce arrhythmogenesis
Heart Rhythm
.
2024 Apr 2:S1547-5271(24)02304-X.
doi: 10.1016/j.hrthm.2024.03.1809.
Online ahead of print.
Authors
Philipp Hegner
1
,
Manuel Schuh
1
,
Felix Wiedmann
2
,
Daniele Camboni
3
,
Christof Schmid
3
,
Lars Siegfried Maier
1
,
Constanze Schmidt
2
,
Stefan Wagner
4
Affiliations
1
Department for Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
2
Department of Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
3
Department of Cardiothoracic Surgery, University Hospital Regensburg, Regensburg, Germany.
4
Department for Internal Medicine II, University Hospital Regensburg, Regensburg, Germany. Electronic address: stefan.wagner@ukr.de.
PMID:
38574786
DOI:
10.1016/j.hrthm.2024.03.1809
No abstract available
Keywords:
Antiarrhythmic therapies; Atrial arrhythmias; Doxapram; Human atrium; K(2P)3.1; TASK-1.